- 全部删除
- 您的购物车当前为空
Numidargistat dihydrochloride (CB-1158 dihydrochloride) 是一种具有口服活性和高效性的精氨酸酶 ( ARG1 ) 抑制剂,是一种免疫肿瘤剂,通过减少晶状体上皮细胞 (LEC) 的增殖和降低纤连蛋白、α-SMA、胶原蛋白 1A1 和波形蛋白的表达来抑制 TGF-β2 诱导的前囊下白内障。
Numidargistat dihydrochloride (CB-1158 dihydrochloride) 是一种具有口服活性和高效性的精氨酸酶 ( ARG1 ) 抑制剂,是一种免疫肿瘤剂,通过减少晶状体上皮细胞 (LEC) 的增殖和降低纤连蛋白、α-SMA、胶原蛋白 1A1 和波形蛋白的表达来抑制 TGF-β2 诱导的前囊下白内障。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,470 | In stock | |
5 mg | ¥ 3,210 | In stock | |
10 mg | ¥ 4,820 | In stock | |
25 mg | ¥ 8,190 | In stock | |
50 mg | ¥ 12,300 | In stock | |
100 mg | ¥ 18,500 | In stock |
Numidargistat dihydrochloride 相关产品
产品描述 | Numidargistat dihydrochloride (CB-1158 dihydrochloride) is an orally active and highly effective arginase (ARG1) inhibitor, an immuno-oncology agent that inhibits TGF-β2-induced subcapsular cataract by reducing the proliferation of lens epithelial cells (LEC) and decreasing the expression of fibronectin, α-SMA, collagen 1A1, and vimentin. |
靶点活性 | Arginase II:296 nM, Arginase I:86 nM |
体外活性 | Numidargistat dihydrochloride 是一种有效的精氨酸酶 (arginase) 抑制剂,抑制重组人 Arg1 (IC50 = 86 nM) 和相关酶 Arg2 (IC50 = 296 nM)。 |
体内活性 | 小鼠癌症模型中,Numidargistat dihydrochloride 通过口服管饲法每天两次以 100 mg/kg 给药,结果显示 Numidargistat dihydrochloride 阻断精氨酸酶,显著抑制 CT26、LLC、B16 和 4T1 肿瘤的生长。[1] |
别名 | INCB01158 dihydrochloride, INCB 01158 dihydrochloride, CB-1158 dihydrochloride ( free base), CB-1158 dihydrochloride, CB1158 dihydrochloride |
分子量 | 360.04 |
分子式 | C11H24BCl2N3O5 |
Smiles | O=C([C@@H](N)C)N1C[C@H](CCCB(O)O)[C@](N)(C(O)=O)C1.Cl.Cl |
密度 | no data available |
存储 | keep away from moisture | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (111.1 mM), Sonication is recommended. H2O: 30 mg/mL (83.32 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容